Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Clinical trial NCT03458728 · TERMINATED

Trial details

NCT number: NCT03458728
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Solid Tumors or Lymphoma in Children Neuroblastoma Osteosarcoma Rhabdomyosarcoma Ewing Sarcoma

Start date: 2018-04-30
Primary completion: 2023-02-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.